Orasis Pharmaceuticals announced that Qlosi (pilocarpine hydrochloride ophthalmic solution) 0.4%, a novel, corrective prescription eye...

When Johnson & Johnson learned of the groundbreaking work from Orasis Pharmaceuticals , an emerging ophthalmic pharmaceuticals company,...

In our pursuit of novelty, we sometimes forget that significant treatment breakthroughs have been made thanks to the reformulation or...

Today, Orasis Pharmaceuticals announced that the U.S. Food and Drug Adminstration (FDA) has accepted its New Drug Application (NDA) for...